Imbewu emnyama - eyaziwa negama layo lezesayensi, i- Nigella sativa - iyinzalo encane evela esitshalweni esiqhakazayo ngegama elifanayo futhi itholakala ezindaweni ezithile eziseNingizimu-mpumalanga ye-Asia. Ngaphandle kwembewu, ungathola futhi imbewu emnyama elungiselelwe emafutheni noma njenge-capsule, engatholakala endaweni yokuphasisa yekhemisi yangakini noma isitolo sokudla kwemvelo.
Eyaziwa nangokuthi i-cumin emnyama, ngezinye izikhathi imbewu encane isetshenziswa njenge-spice e-Middle Eastern naseNdiya, ehlinzeka nge-flavour isinkwa, amaprotheni nezinye izitsha. Imbewu emnyama nayo isetshenziselwe imithi yokwelapha ukuze ilaphe izimo ezihlukahlukene zezokwelapha, kuhlanganise namanye amagciwane, amathumbu emathunjini kanye nokuphefumula. Futhi, nakuba imbewu emnyama okwamanje ifundiswa ngezifo ezihlukahlukene, kunobunye ubufakazi obuthembisayo obukhomba ukuthi imbewu emnyama ingakwazi ukusiza ukugcina amazinga akho e-cholesterol ne-triglyceride ahlolwe.
Ingabe Imbewu Emnyama ingayinciphisa Izindebe Zakho?
Kunezifundo ezimbalwa ezihlola umphumela wembewu emnyama kwizinga le-cholesterol namazinga e-triglyceride. Abantu abahlanganyela kulezi zifundo babe ne-cholesterol ephezulu, isifo sikashukela , isifo se- metabolic noma babekhuluphele kakhulu. Abantu bathatha noma yikuphi phakathi kuka-500 mg kuya ku-2 amagremu enzalo encane echotshoziwe efakwe ku-capsule izinyanga ezimbili.
Nakuba lezi zifundo zingazange zibone ushintsho oluphawulekayo kumazinga e-cholesterol namazinga e-triglyceride, ezinye izifundo zathi:
- Amazinga we- HDL akhulisiwe ngamaphesenti angu-5.
- Amazinga ephelele we-cholesterol anciphisa okungenani amaphesenti angu-5.
- Amazinga e- LDL ama- cholesterol anciphisa ngamaphesenti angu-7.
- Amazinga we- triglyceride anciphisa noma yikuphi phakathi kwamaphesenti angu-8 namaphesenti angu-16.
Ukuhlaziywa okunye kwembulani ukuthi, lapho abantu beyeka ukuthatha isithombo sembewu emnyama, ama-cholesterol awo kanye namazinga e-triglyceride abuyele emazinga ayekho ngaphambi kokuba ukwelashwa kuqala phakathi nenyanga.
Ngaphezu kwalokho, ucwaningo oluthile luveze ukuthi umphumela wokuthi imbewu emnyama inayo yonke i-cholesterol ne-HDL ye-cholesterol i-HDL ingase ixhomeke emzimbeni-ngakho-ke, izithako eziningi zembewu ezithathiwe, umphumela omuhle abangase babe nawo kulezi zinhlobo ze-lipid. Lo mkhuba awuzange uqaphele nge-triglycerides noma amazinga e-LDL.
Izinga LaseNtsundu Eliphansi Lama Lipid?
Kunemibono embalwa ukuthi imbewu emnyama ithinta kanjani ama-cholesterol wakho namazinga e-triglyceride, ngokusekelwe kwizifundo zezilwane:
- Imbewu emnyama inekhono lokunciphisa inani le-cholesterol eyenziwa emzimbeni.
- Imbewu emnyama ingakwazi ukuvimbela i-cholesterol ukuba ingene emgodleni wegazi emathunjini amancane.
- Imbewu emnyama nayo iye yaqaphela ukwandisa inani lama-receptors e-LDL esibindi - esingasiza ukususa i-LDL egazini.
Imbewu emnyama iphezulu e-antioxidant, thymoquinone, kanye namafutha e-polyunsaturated , ama- fiber , nama- phytosterol - konke okucatshangelwa ukuthi kube nomthelela ekwenzeni i-lipid-downing effect ephawulwe ngembewu emnyama.
Ngenxa yokuqukethwe kwayo okunamandla okukhulu, imbewu emnyama ingasiza ekuvimbeleni i-LDL ekubeni yinkinga.
Kubandakanya Imbewu Engumnyama Emigodini Yakho Yokunciphisa I-Lipid
Imiphumela evela kulezi zifundo zivela ethembisayo: imbewu emnyama ibonakala ibe nomthelela omuhle kumazinga e-cholesterol namazinga e-triglyceride. Noma kunjalo, kuzodingeka olunye ulwazi ukuze kuqiniswe lesi sixhumanisi ngaphambi kokuba imbewu encane inganconywa njengengxenye yohlobo lwakho lokuncipha kwe-cholesterol.
Uma unquma ukuzama imbewu emnyama ukwehlisa amazinga akho e-lipid, kufanele ukhulume nomhlinzeki wakho wezempilo kuqala. Nakuba abantu bethatha imbewu emnyama kwezinye zezifundo abazange babone imiphumela emibi kakhulu, aziwa ukuthi uma uthatha imbewu emnyama kuzokwenza noma yiziphi izimo zezokwelapha ongase ube nazo noma uhlanganyele nanoma yimiphi imithi oyithathayo.
> Imithombo:
> Asgary S, Sahebkar A, Goli-malekabadi N. Imiphumela emihle ye-Nigella sativa nge-dyslipidemia. J Endocrinol Invest 2015; 38: 1039-1046.
> Farzaneh E, Nia FR, Mehrtash M, et al Imiphumela ye-8-week Nigella sativa supplementation nokuqeqeshwa kwe-aerobic kuphrofayili ye-lipid kanye ne-VO2 max kuma-sedentary female overweight. Int J Prevent Med 2014; 5: 210-216.
> Ibrahim RM, Hamdan NS, Mahmud R et al. Isivivinyo esilawulwa ngokungahleliwe ngemiphumela ye-hypolipidemic ye-Nigella sativa imbewu ye-powder kubesifazane besilisa. J Trans Med 2014; 12: 82.
> Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N, et al. Ukuhlolwa kwemitholampilo ye-Nigella sativa imbewu yokwelashwa kwe-hyperlipidemia: isilingo somtholampilo esilawulwa ngokungahleliwe, se-placebo. I-Med Arh 2012; 66: 198-200.
> Sahebkar A, Beccuti G, Simental-Mendia LE, et al. Imiphumela ye-Nigella sativa (emnyama) ekugxilweni kwe-plasma lipid kubantu: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta yezilingo ezilawulwe nge-placebo ezilawulwe ngokungahleliwe. I-Pharm Res 2016; 106: 37-50.